These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 9351322)
1. Screening for hemochromatosis encouraged. Blaine JR Mo Med; 1997 Oct; 94(10):612-3. PubMed ID: 9351322 [No Abstract] [Full Text] [Related]
2. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869 [TBL] [Abstract][Full Text] [Related]
3. [Hemochromatosis: the importance of mutation screening in the family]. ter Braak N; Erdkamp FL; van Deursen CT Ned Tijdschr Geneeskd; 2009 Apr; 153(16):765-7. PubMed ID: 19469149 [No Abstract] [Full Text] [Related]
5. Screening for hereditary hemochromatosis. Rochette J; Capron D; Capron JP; Julier C Am J Gastroenterol; 2000 May; 95(5):1368-9. PubMed ID: 10811362 [No Abstract] [Full Text] [Related]
6. Population screening for hemochromatosis--are we finding people with a disease or a biochemical curiosity? Adams PC Semin Gastrointest Dis; 2002 Apr; 13(2):89-94. PubMed ID: 12064864 [TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis 1991. What will increased clinical screening mean for medical directors? Witte DL; Kay BR J Insur Med; 1991; 23(4):281-3. PubMed ID: 10147832 [No Abstract] [Full Text] [Related]
10. Hereditary hemochromatosis: a case study and review. Laudicina RJ; Legrys VA Clin Lab Sci; 2001; 14(3):196-208; quiz 220-2. PubMed ID: 11517631 [TBL] [Abstract][Full Text] [Related]
11. Changing the clinical management of hereditary hemochromatosis: translating screening and early case detection strategies into clinical practice. Hover AR; McDonnell SM; Burke W Arch Intern Med; 2004 May; 164(9):957-61. PubMed ID: 15136303 [TBL] [Abstract][Full Text] [Related]
12. [Prevalence of hereditary hemochromatosis among healthy workers. Diagnostic value of transferrin saturation assay]. Martínez-Vázquez C; Martínez Cadilla J; Gil M; Sopeña B; Torres J; Cordeiro E; Seijas M; de la Fuente J; Méndez MJ An Med Interna; 2000 Dec; 17(12):628-31. PubMed ID: 11213576 [TBL] [Abstract][Full Text] [Related]
13. Implementation of HaemScreen, a workplace-based genetic screening program for hemochromatosis. Nisselle AE; Delatycki MB; Collins V; Metcalfe S; Aitken MA; du Sart D; Halliday J; Macciocca I; Wakefield A; Hill V; Gason A; Warner B; Calabro V; Williamson R; Allen KJ Clin Genet; 2004 May; 65(5):358-67. PubMed ID: 15099342 [TBL] [Abstract][Full Text] [Related]
14. Screening for hemochromatosis. Maguire GA N Engl J Med; 1993 Dec; 329(27):2037. PubMed ID: 8247087 [No Abstract] [Full Text] [Related]
15. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study. Rogowski WH Med Decis Making; 2009; 29(2):224-38. PubMed ID: 19182214 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and current treatments for primary iron overload. Brissot P Am J Hematol; 2007 Dec; 82(12 Suppl):1140-1. PubMed ID: 17963250 [TBL] [Abstract][Full Text] [Related]
17. Should all patients with diabetes mellitus be screened for hemochromatosis? Henderson PC; Dowling P; Ozaki R West J Med; 2002 Mar; 176(2):110-4. PubMed ID: 11897733 [No Abstract] [Full Text] [Related]